I've rebutted most of the negative prognostications

New Post Public Reply Private Reply Replies (0) Message Board

May 16, 2019 at 4:15 AM 200

I've rebutted most of the negative prognostications about zn in previous posts at length

ZN pays as it goes - doesnt get into long term debt-only such long term debt is bonds which are convertible into common stock and thus ultimately wouldnt cost zn much more than fees

much of the hullabaloo re russell index is irrelevant- zn got by for 18 years without being on such- and russell index investors have had 9 months to get out since pps 1st fell below one dollar ca sept 25-27- zn is a spec investment for them and will remain a spec investment for them

most co's like zn apply for another 180 day extension to bring pps to one dollar by building shareholder value-which extensions are regularly granted if the applicant has any reasonable plans-exchanges dont like to lose the 150k in fees /year

if at the end of the 2nd 180 days jan 8,2020 pps is not going to otherwise be over one dollar zn can r/s to stay on the nasdaq-they've signaled their intention in a filing i posted to transfer to another level of the nasdaq during the 2nd 180 days and have not given any indication they would r/s

they/ve never been investigated before and said it was due -though the cause was a complaint by an apparent shorting cartel or entities associated w such who apparently dont politically agree w zn's purposes- sec has not indicated any wrongdoing

price /book of 10 is not unusual for a non-revenue company
price/book and pps for non-revenue co's depends on potential going forward
zn was ca the 5 fastest growth co on nasdaq last june- and if they discover a commercial reservoir they may again be one of the fastest growing- thats one of the reasons they are a spec co invested in by funds looking for spec investments(bc non spec investments usually have small % returns)

and if they discover a commercial field their license would be converted to a 30 yr lease renewable for another 20 years

there is increased activity around zn's license-e.g. delek- which owns 45% of leviathon bought 70% of the license adjacent to zn on the west=
probably figuring the offshore strata may continue under onshore israel- such offshore strata is 5000 to 7000 meters deep- zn's oil shows were near the td bottom at ca 5000 meters w evidence of a petroleum system-
we have no evidence of a delek etc deal but if delek invested in zn's license in some form of deal that would speed things up

if a commercial field is found during the survey this year a new well[possibly from the same pad as the exploratory well(since the 3d survey will surround such well and horizontal drilling can easily extend a few miles now)could be drilled next year,if not sooner if delek etc participated.

in spec co's with no revenue it is not unusual to have price/book ratios of 50-fairly common from what i've seen-and i've seen as high as 200

zn had close to 40m assets til write off due to the noncommercial exploratory well-and if such well aids in discovery of a commercial field due to the 3d survey of 60 square km around the well what then?

they have an experienced C level team w main players having over 30 years experience in oil and gas
and the 3d survey specialist they brought over from viking has 26-28 years of experience/surveys and has supervised as much as 6 wells or surveys and 500 people at a time

the exec compensation committee displayed info showing zn execs were underpaid cf to similar competition and much of their pay is is in stock options to conserve cash-and such options are valued at either the time the option becomes available or is exercised

-so their pay has been much less than some have advertised- those who say zn pps dropped x% should note that the portion of exec pay attributed to stock is much less ,having lost value like everybody else's stock,especially since a filing indicated execs had an agreement to not sell since ca may 17 2017- weeks before the mj1 well was spudded-and execs no doubt restricted themselves to help avoid harmful speculation
and thus execs have not sold stock since may 2017 -except one ex exec who donated stock to nonprofits etc

ceo dustin unselfishly resigned so zn could save money(filing indicated streamlining) as per his resignation letter so his friend Robert Dunn- a 3d specialist from viking -could be brought in as director of operations -if zn again needs a drilling specialist we may see dustin again

drilling plans will be dictated by the 3d survey

Zion Oil & Gas, Inc. (ZNOG) Stock Research Links

ZNOG Board Company Profile Buy Rating Time & Sales News Filings Financials

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Amplifon Data Breach Spurs Legal Scrutiny for Millions

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Webull Faces Class Action Suit: Key Deadlines Loom

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Boston STEM Expo Sparks Young Minds in Engineering

If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...

TCL's Display Future: AI Meets Screens at DTC 2026

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Novo's Semaglutide Shows Promise in MASH Study

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Quantum Space Joins $185M NASA Lunar Transport Deal

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Allergan Aesthetics Study Shows Rising Patient Satisfaction

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Historic Records Set at 2026 CNO Monumental Marathon

Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...

Gildan's Crisis: Investors Face Losses Amid Lawsuit

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...